Diederick Keizer

Diederick Keizer is currently the Manager Clinical Operations at InnoSIGN, where the OncoSIGNal test is used to measure signal transduction pathway activity in a quantitative fashion. Previously, Diederick held various roles in companies such as Philips, NovioSense BV, ZOLL Medical Corporation, Elana B.V., Quintiles, CeloNova BioSciences, KCI Medical, and Medtronic, focusing on clinical operations, strategy development, team management, and key opinion leader contacts. Diederick holds a Master of Science degree in Oncology, Immunology, and Biochemistry from the University of Amsterdam.